Pharmacy Guide

Patient leaflets and SmPCs, drug interaction checker, official dosages and NHS pharmacy opening hours — all in one place.

Pharmacy Guide

Patient leaflets and SmPCs, drug interaction checker, official dosages and NHS pharmacy opening hours — all in one place.

← Back to all medicines

Solvazinc 45mg Effervescent Tablets.

⚠ This medicine appears to have been discontinued

The electronic medicines compendium (emc) no longer publishes a Summary of Product Characteristics for this product, which usually means it is no longer marketed in the UK. The patient leaflet below is kept for reference, but the product may not be available.

If you were prescribed this medicine, other products containing Zinc sulfate monohydrate may still be available. Do not stop your treatment — ask your pharmacist or GP what to use instead.

Active substance: Zinc sulfate monohydrate
Source: electronic medicines compendium (emc)
Official leaflet: Read the PIL on emc

What it is and what it is used for

for

Solvazinc is a mineral supplement used for the treatment of zinc deficiency. Solvazinc 45mg Effervescent Tablets contain zinc (as zinc sulfate monohydrate). Zinc sulfate monohydrate is a source of zinc, which is an essential trace element and involved in a number of body enzyme functions. You must talk to a doctor if you do not feel better or if you feel worse. 2.

What you need to know before you take it

e Solvazinc

Do not take Solvazinc

  • if you are allergic (hypersensitive) to zinc sulfate monohydrate or any of the other ingredients of this medicine (listed in section 6).
  • if you have copper deficiency Talk to your doctor if this applies to you. Warnings and precautions Talk to your doctor, pharmacist or nurse before taking Solvazinc if you suffer from kidney disease. If this applies to you it is important that you tell your doctor or pharmacist before taking Solvazinc and they will decide what to do. It may still be safe for you to take Solvazinc.

1.3.1 Package Leaflet

1

Other medicines and Solvazinc Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines. This is especially important if you are taking or have recently taken any of the following:

  • copper supplements (see section 2 "Do not take Solvazinc….')
  • tetracycline antibiotics (such as oxytetracycline or doxycycline) used to treat certain bacterial infections
  • quinolone antibiotics (such as ciprofloxacin, levofloxacin, moxifloxacin, norfloxacin and ofloxacin) used to treat certain bacterial infections
  • calcium salt preparations
  • iron preparations
  • penicillamine (used to treat rheumatoid arthritis, Wilson's disease, autoimmune hepatitis and cystinuria)
  • trientine (used in the treatment of Wilson's disease) Solvazinc with food and drink Solvazinc should be taken after meals. Pregnancy and breast-feeding The safety of Solvazinc in human pregnancy is not known. Zinc has been shown to cross the placenta and is present in breast milk in females taking zinc supplements. Only take this product during pregnancy or while breast-feeding if your doctor has advised you to do so. Ask your doctor or pharmacist for advice before taking any medicine during pregnancy or while breast-feeding. Driving and using machines Solvazinc is not expected to affect the ability to drive or use machines. Solvazinc contains sorbitol (E420) and sodium Each Solvazinc tablet contains 115.5mg of sorbitol (E420). Sorbitol is a source of fructose. If your doctor has told you that you (or your child) have an intolerance to some sugars or if you have been diagnosed with hereditary fructose intolerance (HFI), a rare genetic disorder in which a person cannot break down fructose, talk to your doctor before you (or your child) take or receive this medicine. This medicine contains 106mg sodium (main component of cooking/table salt) in each tablet. This is equivalent to 5.3% of the recommended maximum daily dietary intake of sodium for an adult. 3.

How to take it

Solvazinc

Always take this medicine exactly as described in this leaflet or as your doctor, pharmacist or nurse have told you. Check with your doctor, pharmacist or nurse if you are not sure. Solvazinc 45mg Effervescent Tablets should be taken orally. The tablets should be dissolved in a glass of water and the solution swallowed.

1.3.1 Package Leaflet

2

Use in adults The recommended dose for adults is one tablet, dissolved in water, once to three times daily after meals. Use in children The recommended dose for children is as follows: More than 30kg: one tablet, dissolved in water, once to three times daily after meals. 10-30kg: half a tablet, dissolved in water, once to three times daily after meals. Less than 10kg: half a tablet, dissolved in water, once daily after a meal. You should not take Solvazinc for any longer than necessary. Your doctor, pharmacist or nurse will advise you on how long you should take Solvazinc. If you take more Solvazinc than you should If you take too many tablets, contact your nearest hospital casualty department or doctor immediately. Take this leaflet and any remaining tablets with you to show the doctor. If you forget to take Solvazinc If you forget to take your tablets, take them as soon as you remember and then continue with the next dose as instructed. Do not take a double dose to make up for a forgotten dose. If you stop taking Solvazinc To get the most benefit from Solvazinc, always finish the course of treatment recommended by your doctor or pharmacist. If you have any further questions on the use of this medicine, ask your doctor, pharmacist or nurse. 4.

Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them. The following side effects have been reported:

  • reduced copper levels, potentially leading to copper deficiency. Signs or symptoms of copper deficiency can include (for example) changes in the way you walk or problems with co-ordinating movements, a tingling or pricking sensation on the skin ('pins and needles' and/or numbness), reduced numbers of red and white blood cells.
  • abdominal pain
  • indigestion
  • nausea (feeling sick)
  • vomiting (being sick)
  • diarrhoea
  • stomach discomfort
  • irritability
  • headache
  • lethargy (a feeling of weariness) Reporting of side effects If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible

Possible side effects

not listed in this leaflet. You can also report side effects directly via the Yellow Card

1.3.1 Package Leaflet

3

Scheme Website: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects you can help provide more information on the safety of this medicine.

5.

How to store it

Solvazinc

Keep this medicine out of the sight and reach of children. Do not use this medicine after the expiry date which is stated on the carton and tablet container. The expiry date refers to the last day of that month. Store this product below 25C. Store in the original packaging to protect the tablets from moisture. Do not take Solvazinc if you notice that the pack or any of the tablets are damaged. Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help to protect the environment. 6.

Contents of the pack and other information

What Solvazinc contains The active substance is zinc (as zinc sulfate monohydrate). Each tablet contains 45mg of elemental zinc (which is equivalent to 125mg of zinc sulfate monohydrate). The other ingredients are: sorbitol (E420), mannitol (E421), sodium hydrogen carbonate, citric acid, saccharin sodium, povidone K25, sodium citrate and sodium carbonate anhydrous. What Solvazinc looks like and contents of the pack Solvazinc is a white, round, flat tablet with bevelled edges. When dissolved in water the solution is clear and colourless. Each box of Solvazinc contains 90 effervescent tablets in three tablet containers of 30. Each tablet container of Solvazinc also contains a small desiccant capsule contained within the cap of the container. This must not be swallowed. Marketing Authorisation Holder Galen Limited Seagoe Industrial Estate Craigavon BT63 5UA UK

1.3.1 Package Leaflet

4

Manufacturer Hermes Pharma GmbH Hans-Urmiller-Ring 52 82515 Wolfratshausen Germany This leaflet was last revised in 06/2025

1.3.1 Package Leaflet

5

Frequently asked questions about Solvazinc 45mg Effervescent Tablets.

How do I take Solvazinc 45mg Effervescent Tablets.?

Solvazinc 45mg Effervescent Tablets. comes as tablet containing 45mg. Always follow the dose your doctor or pharmacist has given you, and read the leaflet that comes with the medicine.

What is the active substance in Solvazinc 45mg Effervescent Tablets.?

The active substance in Solvazinc 45mg Effervescent Tablets. is zinc sulfate monohydrate.

Where does this information come from?

This leaflet reproduces the patient information leaflet approved for Solvazinc 45mg Effervescent Tablets., as published on the electronic medicines compendium (emc). The version printed inside your medicine’s packaging is the one that applies to you.

Can I get Solvazinc 45mg Effervescent Tablets. without a prescription?

Whether a medicine is available over the counter or on prescription only depends on its licence. Check the leaflet, or ask your pharmacist — they can tell you straight away.

About this leaflet

The text above reproduces the patient information leaflet approved for this medicine, restructured for easier reading.

Medical disclaimer: This page is for information only and does not replace advice from your doctor or pharmacist. Always read the leaflet supplied with your medicine. If you are unwell, call NHS 111; in an emergency, call 999.

Medicines with the same active substance: Zinc sulfate monohydrate (1 medicine)
See every medicine containing this substance, or browse the full A–Z of active substances.
⚕For healthcare professionals — Summary of Product Characteristics (SmPC)Full SmPC: dosage, interactions, contraindications, warnings+
Technical information intended for healthcare professionals (doctors and pharmacists). The Summary of Product Characteristics (SmPC) is the official document approved by the MHRA/EMA. It does not replace the patient leaflet or a doctor’s advice.

4.1. Therapeutic indications

Zinc sulfate is a source of zinc which is an essential trace element and involved in a number of body enzyme systems.

Solvazinc®is indicated in adults and children for the treatment of zinc deficiency.

4.2. Posology and method of administration

Method of Administration: oral after dissolution in water.

Adults: One tablet, dissolved in water, once to three times daily after meals.

Children: More than 30kg: One tablet, dissolved in water, once to three times daily after meals.

10-30kg: ½ tablet, dissolved in water, once to three times daily after meals.

Less than 10kg: ½ tablet, dissolved in water, once daily after meals.

4.3. Contraindications

Hypersensitivity to the active substance or any of the excipients listed in section 6.1.

Copper deficiency (see section 4.5).

4.4. Special warnings and precautions for use

Accumulation of zinc may occur in cases of renal failure.

This product contains sorbitol (E420), therefore patients with rare hereditary problems of fructose intolerance should not take this medicine.

This medicinal product contains 106mg sodium per tablet, equivalent to 5.3% of the WHO recommended maximum daily intake of 2g sodium for an adult.

Therapy should continue until clinical improvement occurs and Solvazinc can be replaced by dietary measures unless there is severe malabsorption, metabolic disease or continuing zinc loss. Continued long-term treatment with Solvazinc if zinc deficiency is no longer present may lead to copper deficiency (see section 4.8).

4.5. Interaction with other medicinal products and other forms of interaction

Copper:

Zinc may inhibit the absorption of copper (see section 4.3).

Tetracycline Antibacterials:

Zinc may reduce the absorption of concurrently administered tetracyclines, also the absorption of zinc may be reduced by tetracyclines; when both are being given an interval of at least three hours should be allowed.

Quinolone Antibacterials:

Zinc may reduce the absorption of quinolones; ciprofloxacin, levofloxacin, moxifloxacin, norfloxacin and ofloxacin.

Calcium Salts:

The absorption of zinc may be reduced by calcium salts.

Iron:

The absorption of zinc may be reduced by oral iron, also the absorption of oral iron may be reduced by zinc.

Penicillamine:

The absorption of zinc may be reduced by penicillamine, also the absorption of penicillamine may be reduced by zinc.

Trientine:

The absorption of zinc may be reduced by trientine, also the absorption of trientine may be reduced by zinc.

4.6. Fertility, pregnancy and lactation

The safety of this product in human pregnancy has not been established. Zinc crosses the placenta and is present in breast milk.

4.7. Effects on ability to drive and use machines

Solvazinc® has no influence on the ability to drive and use machines.

4.8. Undesirable effects

Zinc salts may cause abdominal pain, dyspepsia, nausea, vomiting, diarrhoea, gastric irritation and gastritis. There have also been cases of irritability, headache and lethargy observed.

Zinc may interfere with the absorption of copper, leading to reduced copper levels, and potentially copper deficiency. The risk of copper deficiency may be greater with long-term treatment (e.g. if zinc deficiency is no longer present; see Section 4.4) and/or with higher doses of zinc. Signs of copper deficiency can include neurological symptoms e.g. polyneuropathy (symptoms of which can include gait disturbances, ataxia and paraesthesia and/or hypoaesthesia) and haematological symptoms e.g. anaemia, neutropenia, leucopenia and pancytopenia.

Reporting of suspected adverse reactions

Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the Yellow Card Scheme Website: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.

4.9. Overdose

Zinc sulfate is corrosive in overdosage. Symptoms are corrosion and inflammation of the mucous membrane of the mouth and stomach; ulceration of the stomach followed by perforation may occur. Gastric lavage and emesis should be avoided. Demulcents such as milk should be given. Chelating agents such as sodium calcium edetate may be useful.

💬 Ask about this leaflet

Ask anything about Solvazinc 45mg Effervescent Tablets.. The assistant answers only from this leaflet — if the leaflet does not cover it, it will say so. It does not give medical advice.

Answers come from the patient leaflet published on the electronic medicines compendium (emc). They are not medical advice. Ask a pharmacist or your GP if you are unsure. For urgent help call NHS 111, or 999 in an emergency.

Pharmacies in major towns and cities — see the list
Pharmacies by county and region — see the full list

Browse all 2,009 towns and cities →